(VUKE) Vanguard FTSE 100 - Ratings and Ratios
Exchange-Traded Fund, UK Large-Cap Stocks, Equity Exposure
Description: VUKE Vanguard FTSE 100
Vanguards FTSE 100 UCITS ETF (VUKE) is designed to track the performance of the FTSE 100 Index, which comprises the 100 largest largest companies listed on the London Exchange by market capitalization. As a UCITS-compliant ETF listed on Xetra, it offers investors a diversified exposure to the UKs blue-chip companies.
The funds investment objective is to provide replicate the Morningstar UK All Cap TME NR GBP Index, which is includes companies of all sizes in the UK. By tracking this index, VUKE provides broad exposure to the the UK equity market, encompassing various sectors and industries industry segments.
Based on the available data, the current price of the ETF is 46.05. With an S20 of 45.44, S50 of 043.91 and S200 of 043.27, a technical analysis indicates an overall positive trend. Additionally, the ATR1 is 0..37 with a volatility of 0.80%. Given these metrics, a potential trading opportunity could arise if the price were to pull back to the S50 or S200 levels, presenting a buying opportunity.From a fundamental perspective, the VUKEs assets under management (AUM) stand at 49393.074M EUR, indicating a sizable presence in the market. This, combined with the the funds objective to track the the FTSE 100 Index, suggests that that VUKE is a viable option for those seeking exposure to the UK UKs top companies.
Assessing both the technical and fundamental data, a potential potential forecast could be that VUKE continues its upward trend, potentially reaching new highs. If the price were were to consolidate around the current levels, it could present a buying opportunity for investors looking to gain exposure to the UK equity market. However, a decline below the S50 or S200 levels could indicate a reversal in the trend, warranting a reevaluation of the the investment thesis.Additional Sources for VUKE ETF
VUKE ETF Overview
Market Cap in USD | 5,782m |
Category | UK Large-Cap Equity |
TER | 0.10% |
IPO / Inception | 2012-05-22 |
VUKE ETF Ratings
Growth Rating | 77.5 |
Fundamental | - |
Dividend Rating | 54.1 |
Rel. Strength | -15.6 |
Analysts | - |
Fair Price Momentum | 44.61 EUR |
Fair Price DCF | - |
VUKE Dividends
Dividend Yield 12m | 2.49% |
Yield on Cost 5y | 4.18% |
Annual Growth 5y | 10.65% |
Payout Consistency | 82.8% |
Payout Ratio | % |
VUKE Growth Ratios
Growth Correlation 3m | 73.8% |
Growth Correlation 12m | 77% |
Growth Correlation 5y | 96% |
CAGR 5y | 11.62% |
CAGR/Max DD 5y | 0.69 |
Sharpe Ratio 12m | 0.95 |
Alpha | -0.90 |
Beta | 0.506 |
Volatility | 10.70% |
Current Volume | 6.7k |
Average Volume 20d | 2.8k |
As of July 02, 2025, the stock is trading at EUR 44.44 with a total of 6,689 shares traded.
Over the past week, the price has changed by -0.20%, over one month by -1.63%, over three months by +0.62% and over the past year by +9.73%.
Yes. Based on ValueRay's Analyses, Vanguard FTSE 100 (XETRA:VUKE) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.46 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VUKE is around 44.61 EUR . This means that VUKE is currently overvalued and has a potential downside of 0.38%.
Vanguard FTSE 100 has no consensus analysts rating.
According to our own proprietary Forecast Model, VUKE Vanguard FTSE 100 will be worth about 50.2 in July 2026. The stock is currently trading at 44.44. This means that the stock has a potential upside of +12.87%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 50.2 | 12.9% |